News & Events | News
Press releases
Cambridge Healthtech Associates™ Announces arGEN-X as Inaugural Signature Award™...
read more...
arGEN-X granted first US patent covering its unique NHance™...
read more...
BIO International Convention 2012, June 18-21, 2012,... read more... Eighth Annual PEGS 2012, April 30 –... read more... BioCapital Europe 2012, Thursday April 19 2012,... read more... Antibody Biology & Engineering 2012, March 25-30,... read more... arGEN-X launches NHance™ technology to generate better human antibody... read more... arGEN-X appoints Alain Thibault as Chief Medical Officer and... read more... arGEN-X enters into a therapeutic antibody alliance with Shire... read more... arGEN-X advances a third therapeutic antibody program into preclinical... read more... |
